scispace - formally typeset
Y

Yuan-Qiang Hu

Publications -  6
Citations -  852

Yuan-Qiang Hu is an academic researcher. The author has contributed to research in topics: Tuberculosis & Mycobacterium tuberculosis. The author has an hindex of 6, co-authored 6 publications receiving 655 citations.

Papers
More filters
Journal ArticleDOI

Quinoline hybrids and their antiplasmodial and antimalarial activities.

TL;DR: This review aims to summarize the recent advances towards the discovery of antiplasmodial and antimalarial hybrids including quinoline skeleton to provide an insight for rational designs of more active and less toxic quinolines hybrids antimalarials.
Journal ArticleDOI

Recent developments of coumarin-containing derivatives and their anti-tubercular activity

TL;DR: This review outlines the advances in the application of coumarin-containing derivatives as anti-TB agents and the critical aspects of design and structure-activity relationship of these derivatives.
Journal ArticleDOI

4-Quinolone hybrids and their antibacterial activities.

TL;DR: This review aims to summarize the recent advances made towards the discovery of 4-quinolone hybrids as potential antibacterial agents as well as their structure-activity relationship (SAR) and suggests that the enriched SAR may pave the way for the further rational development of 4+1+1 hybrids with excellent potency against both drug-susceptible and drug-resistant bacteria.
Journal ArticleDOI

Isoniazid derivatives and their anti-tubercular activity

TL;DR: Recent advances made towards the discovery anti-TB agents holding INH as a nucleus including INH hybrids and INH hydrazide-hydrazone derivatives are summarized.
Journal ArticleDOI

Azide-alkyne cycloaddition towards 1H-1,2,3-triazole-tethered gatifloxacin and isatin conjugates: Design, synthesis and in vitro anti-mycobacterial evaluation.

TL;DR: Twelve novel 1H-1,2,3-triazole-tethered gatifloxacin (GTFX) isatin conjugates 5a-l with greater lipophilicity compared with GTFX were designed, synthesized and evaluated for in vitro anti-mycobacterial activities against M. tuberculosis (MTB) H37Rv and MDR-TB as well as cytotoxicity.